Loading…
Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors
ATP acts in the extracellular environment as an important signal, activating a family of receptors called purinergic receptors. In recent years, interest in the potential therapeutics of purinergic components, including agonists and antagonists of receptors, has increased. Currently, many observatio...
Saved in:
Published in: | Molecules (Basel, Switzerland) Switzerland), 2023-01, Vol.28 (2), p.590 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3 |
---|---|
cites | cdi_FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3 |
container_end_page | |
container_issue | 2 |
container_start_page | 590 |
container_title | Molecules (Basel, Switzerland) |
container_volume | 28 |
creator | Pacheco, Paulo Anastácio Furtado Gonzaga, Daniel Tadeu Gomes von Ranke, Natalia Lidmar Rodrigues, Carlos Rangel da Rocha, David Rodrigues da Silva, Fernando de Carvalho Ferreira, Vitor Francisco Faria, Robson Xavier |
description | ATP acts in the extracellular environment as an important signal, activating a family of receptors called purinergic receptors. In recent years, interest in the potential therapeutics of purinergic components, including agonists and antagonists of receptors, has increased. Currently, many observations have indicated that ATP acts as an important mediator of inflammatory responses and, when found in high concentrations in the extracellular space, is related to the activation of the P2X7 purinergic receptor. In this sense, the search for new inhibitors for this receptor has attracted a great deal of attention in recent years. Sulfonamide derivatives have been reported to be potent inhibitors of P2X receptors. In this study, ten naphthoquinone sulfonamide derivatives and five naphthoquinone sulfonate ester derivatives were tested for their inhibitory activity on the P2X7 receptor expressed in peritoneal macrophages. Some compounds showed promising results, displaying IC
values lower than that of A740003. Molecular docking and dynamic studies also indicated that the active compounds bind to an allosteric site on P2X7R. The binding free energy indicates that sulfonamides have an affinity for the P2X7 receptor similar to A740003. Therefore, the compounds studied herein present potential P2X7R inhibition. |
doi_str_mv | 10.3390/molecules28020590 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ae2c5d32d00c4f74bc8de85844bc6110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ae2c5d32d00c4f74bc8de85844bc6110</doaj_id><sourcerecordid>2767275121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3</originalsourceid><addsrcrecordid>eNplks2OFCEUhStG4_zoA7gxJG5cTCtQFBQbk3FstZPxJ2lN3BEKbnXToaEFqpN5DN_YKrudzOiKm3vO_YCbU1XPCH5V1xK_3kYPZvCQaYspbiR-UJ0SRvGsxkw-vFOfVGc5bzCmhJHmcXVScy4Eb-hp9Wt5E8oasssX6K2LPq6c0R7N99oPurgYkA4WfTpcpNNYWfAurNCyDNZBRrFHn_VuXdbx5-BCDICWg-9j0FtnR3maPjYKoHkukNA7SG4_wveTntFX-kOgRVi7zpWY8pPqUa99hqfH87z6_n7-7erj7PrLh8XV5fXMMFmXmZANt5R2vSFaSmlEKxorGO9kg422hrUgBAPTdqPCQRiCJdcURMt72kFfn1eLA9dGvVG75LY63aionfrTiGmldCrOeFAaqGlsTS3GhvWCdaa10DYtGytOCB5Zbw6s3dBtwRoIJWl_D3pfCW6tVnGvZMs5ryfAyyMgjXuEXNTWZQPe6wBxyIoK3lLWED5ZX_xj3cQhhXFVk0tQ0RBKRhc5uEyKOSfobx9DsJrCo_4Lzzjz_O4vbif-pqX-DWgxxYw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767275121</pqid></control><display><type>article</type><title>Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Pacheco, Paulo Anastácio Furtado ; Gonzaga, Daniel Tadeu Gomes ; von Ranke, Natalia Lidmar ; Rodrigues, Carlos Rangel ; da Rocha, David Rodrigues ; da Silva, Fernando de Carvalho ; Ferreira, Vitor Francisco ; Faria, Robson Xavier</creator><creatorcontrib>Pacheco, Paulo Anastácio Furtado ; Gonzaga, Daniel Tadeu Gomes ; von Ranke, Natalia Lidmar ; Rodrigues, Carlos Rangel ; da Rocha, David Rodrigues ; da Silva, Fernando de Carvalho ; Ferreira, Vitor Francisco ; Faria, Robson Xavier</creatorcontrib><description>ATP acts in the extracellular environment as an important signal, activating a family of receptors called purinergic receptors. In recent years, interest in the potential therapeutics of purinergic components, including agonists and antagonists of receptors, has increased. Currently, many observations have indicated that ATP acts as an important mediator of inflammatory responses and, when found in high concentrations in the extracellular space, is related to the activation of the P2X7 purinergic receptor. In this sense, the search for new inhibitors for this receptor has attracted a great deal of attention in recent years. Sulfonamide derivatives have been reported to be potent inhibitors of P2X receptors. In this study, ten naphthoquinone sulfonamide derivatives and five naphthoquinone sulfonate ester derivatives were tested for their inhibitory activity on the P2X7 receptor expressed in peritoneal macrophages. Some compounds showed promising results, displaying IC
values lower than that of A740003. Molecular docking and dynamic studies also indicated that the active compounds bind to an allosteric site on P2X7R. The binding free energy indicates that sulfonamides have an affinity for the P2X7 receptor similar to A740003. Therefore, the compounds studied herein present potential P2X7R inhibition.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules28020590</identifier><identifier>PMID: 36677652</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenosine Triphosphate - metabolism ; Allosteric properties ; Antibiotics ; Arthritis ; ATP ; biomass ; Cytokines ; Cytotoxicity ; Disease ; Edema ; Free energy ; heterocycles ; Inflammation ; Inhibitors ; Ligands ; Macrophages ; Metabolism ; Molecular docking ; Molecular Docking Simulation ; Molecular modelling ; naphthoquinones ; Naphthoquinones - chemistry ; Naphthoquinones - pharmacology ; Physiology ; Proteins ; Purine P2X receptors ; Purine receptors ; Purinergic P2X Receptor Antagonists - chemistry ; Purinergic P2X Receptor Antagonists - pharmacology ; Receptors, Purinergic P2X7 ; Simulation ; Sulfonamides ; Sulfonamides - pharmacology ; Sulfonates</subject><ispartof>Molecules (Basel, Switzerland), 2023-01, Vol.28 (2), p.590</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3</citedby><cites>FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3</cites><orcidid>0000-0001-8218-834X ; 0000-0002-7928-8646 ; 0000-0002-2166-766X ; 0000-0002-2042-3778</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2767275121/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2767275121?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,38495,43874,44569,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36677652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pacheco, Paulo Anastácio Furtado</creatorcontrib><creatorcontrib>Gonzaga, Daniel Tadeu Gomes</creatorcontrib><creatorcontrib>von Ranke, Natalia Lidmar</creatorcontrib><creatorcontrib>Rodrigues, Carlos Rangel</creatorcontrib><creatorcontrib>da Rocha, David Rodrigues</creatorcontrib><creatorcontrib>da Silva, Fernando de Carvalho</creatorcontrib><creatorcontrib>Ferreira, Vitor Francisco</creatorcontrib><creatorcontrib>Faria, Robson Xavier</creatorcontrib><title>Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>ATP acts in the extracellular environment as an important signal, activating a family of receptors called purinergic receptors. In recent years, interest in the potential therapeutics of purinergic components, including agonists and antagonists of receptors, has increased. Currently, many observations have indicated that ATP acts as an important mediator of inflammatory responses and, when found in high concentrations in the extracellular space, is related to the activation of the P2X7 purinergic receptor. In this sense, the search for new inhibitors for this receptor has attracted a great deal of attention in recent years. Sulfonamide derivatives have been reported to be potent inhibitors of P2X receptors. In this study, ten naphthoquinone sulfonamide derivatives and five naphthoquinone sulfonate ester derivatives were tested for their inhibitory activity on the P2X7 receptor expressed in peritoneal macrophages. Some compounds showed promising results, displaying IC
values lower than that of A740003. Molecular docking and dynamic studies also indicated that the active compounds bind to an allosteric site on P2X7R. The binding free energy indicates that sulfonamides have an affinity for the P2X7 receptor similar to A740003. Therefore, the compounds studied herein present potential P2X7R inhibition.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Allosteric properties</subject><subject>Antibiotics</subject><subject>Arthritis</subject><subject>ATP</subject><subject>biomass</subject><subject>Cytokines</subject><subject>Cytotoxicity</subject><subject>Disease</subject><subject>Edema</subject><subject>Free energy</subject><subject>heterocycles</subject><subject>Inflammation</subject><subject>Inhibitors</subject><subject>Ligands</subject><subject>Macrophages</subject><subject>Metabolism</subject><subject>Molecular docking</subject><subject>Molecular Docking Simulation</subject><subject>Molecular modelling</subject><subject>naphthoquinones</subject><subject>Naphthoquinones - chemistry</subject><subject>Naphthoquinones - pharmacology</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Purine P2X receptors</subject><subject>Purine receptors</subject><subject>Purinergic P2X Receptor Antagonists - chemistry</subject><subject>Purinergic P2X Receptor Antagonists - pharmacology</subject><subject>Receptors, Purinergic P2X7</subject><subject>Simulation</subject><subject>Sulfonamides</subject><subject>Sulfonamides - pharmacology</subject><subject>Sulfonates</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplks2OFCEUhStG4_zoA7gxJG5cTCtQFBQbk3FstZPxJ2lN3BEKbnXToaEFqpN5DN_YKrudzOiKm3vO_YCbU1XPCH5V1xK_3kYPZvCQaYspbiR-UJ0SRvGsxkw-vFOfVGc5bzCmhJHmcXVScy4Eb-hp9Wt5E8oasssX6K2LPq6c0R7N99oPurgYkA4WfTpcpNNYWfAurNCyDNZBRrFHn_VuXdbx5-BCDICWg-9j0FtnR3maPjYKoHkukNA7SG4_wveTntFX-kOgRVi7zpWY8pPqUa99hqfH87z6_n7-7erj7PrLh8XV5fXMMFmXmZANt5R2vSFaSmlEKxorGO9kg422hrUgBAPTdqPCQRiCJdcURMt72kFfn1eLA9dGvVG75LY63aionfrTiGmldCrOeFAaqGlsTS3GhvWCdaa10DYtGytOCB5Zbw6s3dBtwRoIJWl_D3pfCW6tVnGvZMs5ryfAyyMgjXuEXNTWZQPe6wBxyIoK3lLWED5ZX_xj3cQhhXFVk0tQ0RBKRhc5uEyKOSfobx9DsJrCo_4Lzzjz_O4vbif-pqX-DWgxxYw</recordid><startdate>20230106</startdate><enddate>20230106</enddate><creator>Pacheco, Paulo Anastácio Furtado</creator><creator>Gonzaga, Daniel Tadeu Gomes</creator><creator>von Ranke, Natalia Lidmar</creator><creator>Rodrigues, Carlos Rangel</creator><creator>da Rocha, David Rodrigues</creator><creator>da Silva, Fernando de Carvalho</creator><creator>Ferreira, Vitor Francisco</creator><creator>Faria, Robson Xavier</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8218-834X</orcidid><orcidid>https://orcid.org/0000-0002-7928-8646</orcidid><orcidid>https://orcid.org/0000-0002-2166-766X</orcidid><orcidid>https://orcid.org/0000-0002-2042-3778</orcidid></search><sort><creationdate>20230106</creationdate><title>Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors</title><author>Pacheco, Paulo Anastácio Furtado ; Gonzaga, Daniel Tadeu Gomes ; von Ranke, Natalia Lidmar ; Rodrigues, Carlos Rangel ; da Rocha, David Rodrigues ; da Silva, Fernando de Carvalho ; Ferreira, Vitor Francisco ; Faria, Robson Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Allosteric properties</topic><topic>Antibiotics</topic><topic>Arthritis</topic><topic>ATP</topic><topic>biomass</topic><topic>Cytokines</topic><topic>Cytotoxicity</topic><topic>Disease</topic><topic>Edema</topic><topic>Free energy</topic><topic>heterocycles</topic><topic>Inflammation</topic><topic>Inhibitors</topic><topic>Ligands</topic><topic>Macrophages</topic><topic>Metabolism</topic><topic>Molecular docking</topic><topic>Molecular Docking Simulation</topic><topic>Molecular modelling</topic><topic>naphthoquinones</topic><topic>Naphthoquinones - chemistry</topic><topic>Naphthoquinones - pharmacology</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Purine P2X receptors</topic><topic>Purine receptors</topic><topic>Purinergic P2X Receptor Antagonists - chemistry</topic><topic>Purinergic P2X Receptor Antagonists - pharmacology</topic><topic>Receptors, Purinergic P2X7</topic><topic>Simulation</topic><topic>Sulfonamides</topic><topic>Sulfonamides - pharmacology</topic><topic>Sulfonates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pacheco, Paulo Anastácio Furtado</creatorcontrib><creatorcontrib>Gonzaga, Daniel Tadeu Gomes</creatorcontrib><creatorcontrib>von Ranke, Natalia Lidmar</creatorcontrib><creatorcontrib>Rodrigues, Carlos Rangel</creatorcontrib><creatorcontrib>da Rocha, David Rodrigues</creatorcontrib><creatorcontrib>da Silva, Fernando de Carvalho</creatorcontrib><creatorcontrib>Ferreira, Vitor Francisco</creatorcontrib><creatorcontrib>Faria, Robson Xavier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pacheco, Paulo Anastácio Furtado</au><au>Gonzaga, Daniel Tadeu Gomes</au><au>von Ranke, Natalia Lidmar</au><au>Rodrigues, Carlos Rangel</au><au>da Rocha, David Rodrigues</au><au>da Silva, Fernando de Carvalho</au><au>Ferreira, Vitor Francisco</au><au>Faria, Robson Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2023-01-06</date><risdate>2023</risdate><volume>28</volume><issue>2</issue><spage>590</spage><pages>590-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>ATP acts in the extracellular environment as an important signal, activating a family of receptors called purinergic receptors. In recent years, interest in the potential therapeutics of purinergic components, including agonists and antagonists of receptors, has increased. Currently, many observations have indicated that ATP acts as an important mediator of inflammatory responses and, when found in high concentrations in the extracellular space, is related to the activation of the P2X7 purinergic receptor. In this sense, the search for new inhibitors for this receptor has attracted a great deal of attention in recent years. Sulfonamide derivatives have been reported to be potent inhibitors of P2X receptors. In this study, ten naphthoquinone sulfonamide derivatives and five naphthoquinone sulfonate ester derivatives were tested for their inhibitory activity on the P2X7 receptor expressed in peritoneal macrophages. Some compounds showed promising results, displaying IC
values lower than that of A740003. Molecular docking and dynamic studies also indicated that the active compounds bind to an allosteric site on P2X7R. The binding free energy indicates that sulfonamides have an affinity for the P2X7 receptor similar to A740003. Therefore, the compounds studied herein present potential P2X7R inhibition.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36677652</pmid><doi>10.3390/molecules28020590</doi><orcidid>https://orcid.org/0000-0001-8218-834X</orcidid><orcidid>https://orcid.org/0000-0002-7928-8646</orcidid><orcidid>https://orcid.org/0000-0002-2166-766X</orcidid><orcidid>https://orcid.org/0000-0002-2042-3778</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1420-3049 |
ispartof | Molecules (Basel, Switzerland), 2023-01, Vol.28 (2), p.590 |
issn | 1420-3049 1420-3049 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ae2c5d32d00c4f74bc8de85844bc6110 |
source | Publicly Available Content Database; PubMed Central; Coronavirus Research Database |
subjects | Adenosine Triphosphate - metabolism Allosteric properties Antibiotics Arthritis ATP biomass Cytokines Cytotoxicity Disease Edema Free energy heterocycles Inflammation Inhibitors Ligands Macrophages Metabolism Molecular docking Molecular Docking Simulation Molecular modelling naphthoquinones Naphthoquinones - chemistry Naphthoquinones - pharmacology Physiology Proteins Purine P2X receptors Purine receptors Purinergic P2X Receptor Antagonists - chemistry Purinergic P2X Receptor Antagonists - pharmacology Receptors, Purinergic P2X7 Simulation Sulfonamides Sulfonamides - pharmacology Sulfonates |
title | Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A13%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20Biological%20Evaluation%20and%20Molecular%20Modeling%20Studies%20of%20Naphthoquinone%20Sulfonamides%20and%20Sulfonate%20Ester%20Derivatives%20as%20P2X7%20Inhibitors&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Pacheco,%20Paulo%20Anast%C3%A1cio%20Furtado&rft.date=2023-01-06&rft.volume=28&rft.issue=2&rft.spage=590&rft.pages=590-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules28020590&rft_dat=%3Cproquest_doaj_%3E2767275121%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-7956d22bfc1a999c7875d746b950cadc48e774ec8b7876e7c1096a2e786f2bef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2767275121&rft_id=info:pmid/36677652&rfr_iscdi=true |